DI-015 Safety of dimethyl fumarate in the treatment of relapsing remitting multiple sclerosis: a retrospective study

BackgroundDimethyl fumarate (DMF) represents a new class of treatment for patients with relapsing remitting multiple sclerosis (RRMS). Scientific investigations are still in progress to clarify the ultimate mechanism of action responsible for the treatment effects of DMF. DMF does not have a single...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2017-03, Vol.24 (Suppl 1), p.A119-A119
Hauptverfasser:	Tauste-Hernandez, B, Fernández-Ginés, FD, Cañizares-Paz, S, Sierra-García, F, Molina-Cuadrado, E
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical trials Multiple sclerosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!